|
1
|
Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients.
|
Nephrol Dial Transplant
|
2005
|
1.61
|
|
2
|
Reg2 inactivation increases sensitivity to Fas hepatotoxicity and delays liver regeneration post-hepatectomy in mice.
|
Hepatology
|
2006
|
1.61
|
|
3
|
Plasma-induced endothelial oxidative stress is related to the severity of septic shock.
|
Crit Care Med
|
2007
|
1.57
|
|
4
|
Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.
|
Nephrol Dial Transplant
|
2007
|
1.53
|
|
5
|
Increased pasma S-nitrosothiol concentrations predict cardiovascular outcomes among patients with end-stage renal disease: a prospective study.
|
J Am Soc Nephrol
|
2004
|
1.51
|
|
6
|
Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
|
J Am Soc Nephrol
|
2004
|
1.44
|
|
7
|
Increased plasma S-nitrosothiol levels in chronic haemodialysis patients.
|
Nephrol Dial Transplant
|
2003
|
1.43
|
|
8
|
Incidence of anaemia, and use of epoetin therapy in pre-dialysis patients: a prospective study in 403 patients.
|
Nephrol Dial Transplant
|
2002
|
1.40
|
|
9
|
The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice.
|
Kidney Int
|
2005
|
1.16
|
|
10
|
Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients.
|
Am J Kidney Dis
|
2005
|
1.15
|
|
11
|
Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
|
Circulation
|
2005
|
1.14
|
|
12
|
Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes.
|
Am J Respir Crit Care Med
|
2005
|
1.03
|
|
13
|
Cystic fibrosis transmembrane regulator inhibitors CFTR(inh)-172 and GlyH-101 target mitochondrial functions, independently of chloride channel inhibition.
|
J Pharmacol Exp Ther
|
2010
|
0.99
|
|
14
|
The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.
|
Atherosclerosis
|
2008
|
0.99
|
|
15
|
Peroxiredoxin 6 fails to limit phospholipid peroxidation in lung from Cftr-knockout mice subjected to oxidative challenge.
|
PLoS One
|
2009
|
0.97
|
|
16
|
Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers.
|
Kidney Int
|
2004
|
0.95
|
|
17
|
Oxidative stress and chronic renal failure: markers and management.
|
J Nephrol
|
2002
|
0.95
|
|
18
|
Dietary salt restriction accelerates atherosclerosis in apolipoprotein E-deficient mice.
|
Atherosclerosis
|
2005
|
0.92
|
|
19
|
Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
|
J Urol
|
2008
|
0.90
|
|
20
|
Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment.
|
Proteomics
|
2006
|
0.88
|
|
21
|
[Continued late referral of patients with chronic kidney disease. Causes, consequences, and approaches to improvement].
|
Presse Med
|
2006
|
0.85
|
|
22
|
Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure.
|
Bone
|
2010
|
0.85
|
|
23
|
Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
|
Nephrol Dial Transplant
|
2007
|
0.84
|
|
24
|
GSH monoethyl ester rescues mitochondrial defects in cystic fibrosis models.
|
Hum Mol Genet
|
2011
|
0.84
|
|
25
|
Glutathione S-transferases related to P. aeruginosa lung infection in cystic fibrosis children: preliminary study.
|
Clin Biochem
|
2008
|
0.84
|
|
26
|
Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
|
Nephrol Dial Transplant
|
2011
|
0.81
|
|
27
|
A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients.
|
J Proteome Res
|
2014
|
0.81
|
|
28
|
Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice.
|
Atherosclerosis
|
2013
|
0.76
|
|
29
|
Could proteinuria evaluation be helpful in predicting renal progression in apolipoprotein E-deficient (E-/-) mice with chronic renal failure?
|
Nephrol Dial Transplant
|
2004
|
0.75
|
|
30
|
[Frequency of anaemia and indications for treatment with epoetin in chronic renal failure at the pre-dialysis stage].
|
Presse Med
|
2003
|
0.75
|
|
31
|
New insights into the effects of the protein moiety of oxidized LDL (oxLDL).
|
Kidney Int Suppl
|
2003
|
0.75
|